Kairos Pharma Balance Sheet (2024-2025) | KAPA

Balance Sheet Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter) 3.22M3.62M3.03M4.49M
Cash & Current Investments (Quarter) 3.22M3.62M3.03M4.49M
Prepaid Assets (Quarter) 0.01M0.04M0.06M0.09M0.05M
Current Assets (Quarter) 4.74M4.17M6.05M4.84M5.39M
Non-Current Assets
Intangibles (Quarter) 0.26M0.22M0.18M0.14M0.06M
Goodwill & Intangibles (Quarter) 0.26M0.22M0.18M0.14M0.06M
Other Non-Current Assets (Quarter) 1.38M1.71M1.69M1.09M
Non-Current Assets (Quarter) 0.26M1.60M1.89M1.83M1.15M
Assets (Quarter) 5.00M5.77M7.94M6.67M6.54M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 1.53M0.99M0.81M0.68M0.20M
Notes Payables (Quarter) 0.79M
Payables (Quarter) 2.32M0.99M0.81M0.68M0.20M
Total Current Liabilities (Quarter) 1.67M0.99M0.81M0.68M0.20M
Non-Current Liabilities
Total Non-Current Liabilities (Quarter) 1.67M0.99M
Total Liabilities (Quarter) 2.40M2.65M1.67M0.99M0.81M0.68M0.20M
Shareholder's Equity
Common Equity (Quarter) -2.40M-2.65M3.33M4.78M7.13M6.00M6.34M
Shareholder's Equity (Quarter) -2.40M-2.65M3.33M4.78M7.13M6.00M6.34M
Liabilities and Shareholders Equity (Quarter) 5.00M5.77M7.94M6.67M6.54M
Retained Earnings (Quarter) -7.83M-8.81M-10.08M-11.50M-14.26M
Treasury Shares (Quarter) 0.28M0.28M3.94M3.94M4.15M